USPTO serial 79426787
Reviewed by CopyMark Law Group
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical preparations, namely, therapeutic agents or vaccines, comprising nucleic acids, peptides or proteins intended for use in the intracellular prevention or treatment of diseases or disorders. | SECTION 70 - CANCELLED | — |
| 042 | Scientific research in the field of therapeutics or vaccines, comprising nucleic acids, peptides or proteins intended for use in the intracellular prevention or treatment of diseases or disorders. | SECTION 70 - CANCELLED | — |
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
| Date | Code | Event | What it means |
|---|---|---|---|
| Oct 3, 2025 | DETH | DEATH OF INTERNATIONAL REGISTRATION | — |
| Sep 10, 2025 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Sep 9, 2025 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 8, 2025 | DOCK | ASSIGNED TO EXAMINER | — |
| Jun 27, 2025 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Jun 27, 2025 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jun 26, 2025 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |